অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

douglas pharmaceuticals australia pty ltd - isotretinoin, quantity: 5 mg - capsule, soft - excipient ingredients: purified water; glycerol; hydrogenated vegetable oil; partially hydrogenated soya oil; butylated hydroxyanisole; gelatin; dl-alpha-tocopherol; titanium dioxide; yellow beeswax; disodium edetate; sorbitol solution (70 per cent) (non-crystallising); soya oil - isotretinoin ascent is indicated for the treatment of patients with severe cystic acne and a single course of therapy has been shown to result in complete and prolonged remission of disease in many patients. if a second course of therapy is needed, it should not be initiated until at least eight weeks after completion of the first course, since experience has shown that patients may continue to improve while off the drug. because of significant adverse effects associated with its use, isotretinoin should be reserved for patients with severe cystic acne who are unresponsive to conventional therapy, including systemic antibiotics.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

douglas pharmaceuticals australia pty ltd - isotretinoin, quantity: 20 mg - capsule, soft - excipient ingredients: titanium dioxide; butylated hydroxyanisole; gelatin; glycerol; disodium edetate; brilliant scarlet 4r; yellow beeswax; purified water; hydrogenated vegetable oil; indigo carmine; sorbitol solution (70 per cent) (non-crystallising); dl-alpha-tocopherol; soya oil; partially hydrogenated soya oil - isotretinoin-ga is indicated for the treatment of severe cystic acne and a single course of therapy has been shown to result in complete and prolonged remission of disease in many patients. if a second course of therapy is needed, it should not be initiated until at least eight weeks after completion of the first course, since experience has shown that patients may continue to improve while off the drug. because of significant adverse effects associated with its use. isotretinoin should be reversed for patients with severe cystic acne who are unresponsive to conventional therapy, including systemic antibiotics.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

douglas pharmaceuticals australia pty ltd - isotretinoin, quantity: 10 mg - capsule, soft - excipient ingredients: gelatin; butylated hydroxyanisole; glycerol; yellow beeswax; titanium dioxide; sorbitol solution (70 per cent) (non-crystallising); iron oxide black; disodium edetate; purified water; brilliant scarlet 4r; partially hydrogenated soya oil; soya oil; hydrogenated vegetable oil; dl-alpha-tocopherol - isotretinoin-ga is indicated for the treatment of severe cystic acne and a single course of therapy has been shown to result in complete and prolonged remission of disease in many patients. if a second course of therapy is needed, it should not be initiated until at least eight weeks after completion of the first course, since experience has shown that patients may continue to improve while off the drug. because of significant adverse effects associated with its use, isotretinoin should be reserved for patients with severe cystic acne who are unresponsive to conventional therapy, including systemic antibiotics.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

douglas pharmaceuticals australia pty ltd - isotretinoin, quantity: 5 mg - capsule, soft - excipient ingredients: disodium edetate; partially hydrogenated soya oil; glycerol; soya oil; sorbitol solution (70 per cent) (non-crystallising); yellow beeswax; dl-alpha-tocopherol; titanium dioxide; gelatin; hydrogenated vegetable oil; purified water; butylated hydroxyanisole - isotretinoin-ga is indicated for the treatment of patients with severe cystic acne and a single course of therapy has been shown to result in complete and prolonged remission of disease in many patients. if a second course of therapy is needed, it should not be initiated until at least eight weeks after completion of the first course, since experience has shown that patients may continue to improve while off the drug. because of significant adverse effects associated with its use, isotretinoin should be reserved for patients with severe cystic acne who are unresponsive to conventional therapy, including systemic antibiotics.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

douglas pharmaceuticals australia pty ltd - isotretinoin, quantity: 20 mg - capsule, soft - excipient ingredients: dl-alpha-tocopherol; indigo carmine; soya oil; sorbitol solution (70 per cent) (non-crystallising); brilliant scarlet 4r; hydrogenated vegetable oil; gelatin; titanium dioxide; glycerol; yellow beeswax; purified water; butylated hydroxyanisole; disodium edetate; partially hydrogenated soya oil - isotretinoin-as is indicated for the treatment of severe cystic acne and a single course of therapy has been shown to result in complete and prolonged remission of disease in many patients. if a second course of therapy is needed, it should not be initiated until at least eight weeks after completion of the first course, since experience has shown that patients may continue to improve while off the drug. because of significant adverse effects associated with its use. isotretinoin should be reversed for patients with severe cystic acne who are unresponsive to conventional therapy, including systemic antibiotics.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

douglas pharmaceuticals australia pty ltd - isotretinoin, quantity: 10 mg - capsule, soft - excipient ingredients: butylated hydroxyanisole; soya oil; dl-alpha-tocopherol; iron oxide black; disodium edetate; sorbitol solution (70 per cent) (non-crystallising); gelatin; titanium dioxide; partially hydrogenated soya oil; yellow beeswax; hydrogenated vegetable oil; purified water; brilliant scarlet 4r; glycerol - isotretinoin-as is indicated for the treatment of severe cystic acne and a single course of therapy has been shown to result in complete and prolonged remission of disease in many patients. if a second course of therapy is needed, it should not be initiated until at least eight weeks after completion of the first course, since experience has shown that patients may continue to improve while off the drug. because of significant adverse effects associated with its use, isotretinoin should be reserved for patients with severe cystic acne who are unresponsive to conventional therapy, including systemic antibiotics.

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

douglas pharmaceuticals australia pty ltd - isotretinoin, quantity: 5 mg - capsule, soft - excipient ingredients: titanium dioxide; yellow beeswax; butylated hydroxyanisole; sorbitol solution (70 per cent) (non-crystallising); partially hydrogenated soya oil; soya oil; hydrogenated vegetable oil; disodium edetate; gelatin; glycerol; purified water; dl-alpha-tocopherol - isotretinoin-as is indicated for the treatment of patients with severe cystic acne and a single course of therapy has been shown to result in complete and prolonged remission of disease in many patients. if a second course of therapy is needed, it should not be initiated until at least eight weeks after completion of the first course, since experience has shown that patients may continue to improve while off the drug. because of significant adverse effects associated with its use, isotretinoin should be reserved for patients with severe cystic acne who are unresponsive to conventional therapy, including systemic antibiotics.

যুক্তরাজ্য - ইংরেজি - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - isotretinoin - oral capsule - 40mg

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - isotretinoin (unii: eh28up18if) (isotretinoin - unii:eh28up18if) - isotretinoin 10 mg - claravis (isotretinoin capsules) is indicated for the treatment of severe recalcitrant nodular acne. nodules are inflammatory lesions with a diameter of 5 mm or greater. the nodules may become suppurative or hemorrhagic. “severe,” by definition,2 means “many” as opposed to “few or several” nodules. because of significant adverse effects associated with its use, claravis should be reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics. in addition, claravis is indicated only for those patients who are not pregnant, because claravis can cause life threatening birth defects (see boxed contraindications and warnings ). a single course of therapy for 15 to 20 weeks has been shown to result in complete and prolonged remission of disease in many patients.1,3,4 if a second course of therapy is needed, it should not be initiated until at least 8 weeks after completion of the first course, because experience has shown that patients may continue to

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

physicians total care, inc. - isotretinoin (unii: eh28up18if) (isotretinoin - unii:eh28up18if) - isotretinoin 20 mg - claravis (isotretinoin capsules, usp) is indicated for the treatment of severe recalcitrant nodular acne. nodules are inflammatory lesions with a diameter of 5 mm or greater. the nodules may become suppurative or hemorrhagic. “severe,” by definition,2 means “many” as opposed to “few or several” nodules. because of significant adverse effects associated with its use, claravis should be reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics. in addition, claravis is indicated only for those female patients who are not pregnant, because claravis can cause severe birth defects (see boxed contraindications and warnings ). a single course of therapy for 15 to 20 weeks has been shown to result in complete and prolonged remission of disease in many patients.1,3,4 if a second course of therapy is needed, it should not be initiated until at least 8 weeks after completion of the first course, because experience has shown that patients may continue